Organization

Alterity Therapeutics Limited

About

Alterity Therapeutics is a clinical-stage biotechnology company focused on broad drug discovery for people living with neurodegenerative diseases. The company’s discovery platform generates patentable chemicals to intervene in disease processes. ATH434 is the company’s lead asset that has potential to treat multiple different forms of Parkinsonian disorders.

Overview

Founded 1997
Type Public
Location Melbourne, Victoria, Australia

Stock

ATHE $0.48 6.02% $0.03

Latest News

Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket Sep 20, 2022 Benzinga Gainers BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) rose 58.2% to $8.70 in pre-market trading. BYND Cannasoft shares jumped over 32% on Monday after the company...
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 Aug 03, 2022 Benzinga Upgrades Bernstein upgraded the previous rating for Cognex Corp (NASDAQ:CGNX) from Market Perform to Outperform. In the second quarter, Cognex showed an EPS of $0.41,...
Hot Penny Stocks to Watch Right Now That Are Moving in Premarket Jan 06, 2022 PennyStocks These penny stocks climbed during premarket trading, here's why The post Hot Penny Stocks to Watch Right Now That Are Moving in Premarket appeared first...
Hot Robinhood Penny Stocks For Your Watchlist in 2021 Aug 04, 2021 PennyStocks Robinhood penny stocks are in focus right now; here's 3 to watch The post Hot Robinhood Penny Stocks For Your Watchlist in 2021 appeared first...
What's Sending Alterity Therapeutics Shares Higher? Jul 01, 2021 Benzinga Shares of Australian biopharma Alterity Therapeutics Limited (NASDAQ: ATHE) were trading solidly higher Thursday. What Happened: Alterity announced the U.S. Patent and Trademark Office granted...